For a decade, the most powerful non-statin cholesterol drugs have come with a catch: they had to be injected. That changed ...

Updated cholesterol guidelines could make more than half of adults ages 30 to 79 in the United States eligible for statins.

Patients who need to lower their cholesterol will soon have a powerful new option. On Thursday, the Food and Drug ...

Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way from a statin to lower cholesterol.

Recommendations expand treatment to millions of younger, lower-risk adults.

Can a low-carb diet cause your cholesterol to skyrocket? This question has vexed researchers and influencers alike as the ...

It could have a big impact on your future health, too.

The pill, branded as Lipfendra, is intended to treat patients with hypercholesterolemia, including those with hereditary ...

Medical News Today spoke to three experts to discuss what the 2026 AHA/ACC cholesterol guideline means for managing LDL ...

The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol.

The Food and Drug Administration approved a drug earlier this month that may change how high cholesterol is treated. More than 86 million people in the United States have cholesterol that is ...

FDA-approved Lipfendra, the first oral PCSK9 inhibitor, which can cut LDL or "bad" cholesterol by nearly 60%.